Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

11 Feb 2010 07:00

RNS Number : 9785G
Carclo plc
11 February 2010
Β 

ο»Ώ

11 February 2010

Β 

Carclo plc

("Carclo" or "the group")

Β 

Interim Management Statement

Β 

The board of Carclo is pleased to confirm that trading in the second half of the financial year is continuing in line with its expectations. Divisional operating profits should be well ahead of the first half and underlying profits for the full year are expected to be at a broadly similar level to last year. The Technical Plastics division continues to perform well and win new business in medical and optical. In Precision Products, demand in our aerospace businesses remains subdued but Wipac is seeing a stronger second half, benefitting from its supercar lighting programmes.

Β 

In December 2009 Carclo and Conductive Inkjet Technology ("CIT") announced that an agreement had been signed with Atmel Corporation ("Atmel") for the development and launch of an innovative touch screen product based on CIT's patented photolithographic film. CIT is on track to install a production line in its Cambridge facility for the manufacture of touch screen sensors which should be operational by the end of this calendar year. Atmel has made a payment to CIT of $0.5 million to secure preferential access to CIT's capacity with further payments of up to $0.5 million due once the production line is installed and commissioned.

Β 

Since the half year results were announced, the group has raised Β£3.5 million in cash, net of costs, through a placing of 2,858,000 new Carclo shares. This 5% placing was achieved at a nil discount to the prevailing mid market price and the funds are being used to accelerate a number of growth opportunities, primarily at CIT. This fundraising will enable the group to continue to reduce debt levels whilst investing in its growth businesses.

Β 

The group's finances remain strong, its main businesses continue to demonstrate their underlying strengths and CIT is now commercialising rapidly. The board is confident of delivering further progress in the next financial year.

Β 

- ENDS -

Β 

Β 

Enquiries:

Β 

Β 

Β 

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Β 

Robert Brooksbank, Finance Director

Β 

Β 

Β 

Weber Shandwick Financial

Β 020 7067 0700

Terry Garrett / Stephanie Badjonat / Clare Thomas

Β 

Β 

Notes to editors

Β 

Β·; Carclo plc is a global supplier of technical plastic components. It is a public company whose shares are quoted on the London Stock Exchange.

Β 

Β·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

Β 

Β·; One third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries.

Β 

Β·; Carclo's strategy is to develop new technologies and products to drive future growth.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGGUAAPUPUGQU
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.